发明名称 |
Combination therapy with type I and type II anti-CD20 antibodies |
摘要 |
The present invention is directed to a combination therapy involving a type I anti-CD20 antibody and a type II anti-CD20 antibody for the treatment of a patient suffering from cancer, particularly a CD20-expressing cancer. An aspect of the invention is a composition comprising a type I anti-CD20 antibody and a type II anti-CD20 antibody. Another aspect of the invention is a kit comprising a type I anti-CD20 antibody and a type II anti-CD20 antibody. Yet another aspect of the invention is a method for the treatment of a patient suffering from cancer comprising co-administering, to a patient in need of such treatment, a type I anti-CD20 antibody and a type II anti-CD20 antibody. |
申请公布号 |
AU2008295140(A1) |
申请公布日期 |
2009.03.12 |
申请号 |
AU20080295140 |
申请日期 |
2008.08.20 |
申请人 |
F. HOFFMANN-LA ROCHE AG;ROCHE GLYCART AG |
发明人 |
THOMAS FRIESS;PABLO UMANA;CHRISTIAN KLEIN |
分类号 |
C07K16/28;A61K39/395;A61P35/02 |
主分类号 |
C07K16/28 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|